1. Home
  2. IX vs ILMN Comparison

IX vs ILMN Comparison

Compare IX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

HOLD

Current Price

$39.26

Market Cap

41.7B

Sector

Finance

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$270.57

Market Cap

37.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IX
ILMN
Founded
1950
1998
Country
Japan
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7B
37.0B
IPO Year
1999
2000

Fundamental Metrics

Financial Performance
Metric
IX
ILMN
Price
$39.26
$270.57
Analyst Decision
Hold
Analyst Count
0
17
Target Price
N/A
★ $124.24
AVG Volume (30 Days)
244.0K
★ 2.2M
Earning Date
05-11-2026
04-30-2026
Dividend Yield
★ 2.33%
N/A
EPS Growth
N/A
★ 170.87
EPS
N/A
★ 2.22
Revenue
N/A
★ $4,343,000,000.00
Revenue This Year
$12.73
$6.47
Revenue Next Year
$4.32
$5.58
P/E Ratio
★ $12.93
$123.38
Revenue Growth
★ N/A
N/A
52 Week Low
$24.19
$88.00
52 Week High
$42.39
$277.95

Technical Indicators

Market Signals
Indicator
IX
ILMN
Relative Strength Index (RSI) 48.78 77.89
Support Level $39.10 $116.43
Resistance Level $40.20 N/A
Average True Range (ATR) 0.42 11.84
MACD -0.08 5.39
Stochastic Oscillator 55.29 97.23

Price Performance

Historical Comparison
IX
ILMN

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: